Emotional dysfunction in Parkinson's disease.
作者： John T. Slevin , Lee X. Blonder
关键词:
摘要: In addition to motor symptomatology, idiopathic Parkinson's disease is characterized by emotional dysfunction. Depression affects some 30 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety apathy. Neuropsychological neuroimaging studies dysfunction in suggest abnormalities involving mesolimbic mesocortical dopaminergic pathways. There also evidence suggesting that the interaction between serotonin dopamine systems important understanding treatment mood disorders disease. this review we discuss neuropsychiatric accompany describe their neuropsychological, neuropharmacologic, concomitants.
hindawi.com参考文章(167)
Depression and disability in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences. ,vol. 8, pp. 20- 25 ,(1996) , 10.1176/JNP.8.1.20
Richard Hegeman, The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD Neuropsychiatric Disease and Treatment. ,vol. 3, pp. 903- 906 ,(2008) , 10.2147/NDT.S1214
Jeffrey L Cummings, Depression and Parkinson's disease: a review. American Journal of Psychiatry. ,vol. 149, pp. 443- 454 ,(1992) , 10.1176/AJP.149.4.443
O Spigset, C von Schéele, Levodopa Dependence and Abuse in Parkinson's Disease Pharmacotherapy. ,vol. 17, pp. 1027- 1030 ,(1997) , 10.1002/J.1875-9114.1997.TB03794.X
Jerome A. Yesavage, Javaid I. Sheikh, Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontologist. ,vol. 5, pp. 165- 173 ,(1986) , 10.1300/J018V05N01_09
G DIGIOVANNI, V DIMATTEO, M PIERUCCI, E ESPOSITO, Serotonin-dopamine interaction: electrophysiological evidence. Progress in Brain Research. ,vol. 172, pp. 45- 71 ,(2008) , 10.1016/S0079-6123(08)00903-5
R. Jouvent, P. Abensour, A.M. Bonnet, D. Widlocher, Y. Agid, F. Lhermitte, Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison. Journal of Affective Disorders. ,vol. 5, pp. 141- 145 ,(1983) , 10.1016/0165-0327(83)90006-X
V DIMATTEO, G DIGIOVANNI, M PIERUCCI, E ESPOSITO, Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Progress in Brain Research. ,vol. 172, pp. 7- 44 ,(2008) , 10.1016/S0079-6123(08)00902-3
Charles D. Spielberger, Richard L. Gorsuch, R. E. Lushene, Manual for the State-Trait Anxiety Inventory Consulting Psychologist. ,(1970)
P. Barone, L. Scarzella, R. Marconi, A. Antonini, L. Morgante, F. Bracco, M. Zappia, B. Musch, , Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. Journal of Neurology. ,vol. 253, pp. 601- 607 ,(2006) , 10.1007/S00415-006-0067-5